The Metabolic Power of the Peptide AOD 9604 Episode #31 | The Dylan Gemelli Podcast | Released June 2, 2025

Introduction

In Episode #31 of The Dylan Gemelli Podcast, host Dylan Gemelli delves deep into the burgeoning world of peptides, with a particular focus on AOD 9604, also known as Anti-Obesity Drug 9604. AOD 9604 has been gaining traction as a potential game-changer in metabolic enhancement and weight management. Throughout the episode, Dylan explores its mechanisms, benefits, safety profile, and its positioning as an alternative or complement to GLP-1s (Glucagon-Like Peptide-1 receptor agonists).

1. Understanding AOD 9604

Dylan begins by introducing AOD 9604, clarifying that it stands for Anti-Obesity Drug 9604. He explains that it is a synthetic peptide fragment derived from the C-terminal end of human growth hormone (HGH). "AOD9604 is actually just a synthetic peptide fragment derived from the C terminal end of human growth hormone" (00:18).

Originally developed to combat obesity, AOD 9604 is now recognized for its multifaceted benefits, including promoting fat loss, boosting metabolic function, and supporting joint health. Unlike exogenous HGH, AOD 9604 offers these advantages without the associated adverse effects such as negative impacts on blood sugar or insulin sensitivity.

2. Mechanism of Action

Dylan provides a comprehensive breakdown of how AOD 9604 operates within the body:

• Selective Lipolytic Activity: AOD 9604 targets fat burning specifically, enhancing metabolic efficiency without causing muscle loss. "It's going to increase your metabolic rate, but the beauty of that is without muscle loss" (00:50).

• Upregulation of Fat-Metabolizing Enzymes: It boosts caloric expenditure during rest while sparing lean muscle mass, which is crucial for long-term weight management.

• Activation of Fat-Burning Receptors: AOD 9604 stimulates beta-3 receptors in adipose fat tissue, initiating the conversion of triglycerides into free fatty acids and glycerol for energy production (05:10).

• Improvement of Insulin Sensitivity: Enhancing how the body responds to insulin can lower the risk of type 2 diabetes and stabilize blood glucose levels (07:35).

Dylan emphasizes the importance of understanding the "why" and "how" behind AOD 9604's fat-burning capabilities, moving beyond superficial explanations.

3. Clinical Evidence and Benefits

While acknowledging limited human trials, Dylan references preclinical studies in mice and rats that demonstrated AOD 9604's ability to stimulate lipolysis, inhibit lipogenesis, and prevent weight gain. A notable human study cited showed significant reductions in abdominal and total body fat without serious side effects.

Beyond weight loss, AOD 9604 offers additional health benefits:

• Joint and Cartilage Repair: Studies, including a 2015 animal model of osteoarthritis, indicated that AOD 9604 combined with hyaluronic acid significantly improved cartilage healing (15:45).

• Enhanced Mobility: By reducing joint inflammation and pain, individuals can increase their physical activity levels, creating a positive feedback loop for accelerated fat loss and improved cardiovascular health.

• Metabolic Health: AOD 9604 supports essential metabolic processes, including blood sugar balance, hormone regulation, energy production, and fat utilization.

4. Comparing AOD 9604 to Traditional Weight Loss Methods

Dylan contrasts AOD 9604 with conventional weight loss strategies such as diets and exercise:

• Targeted Fat Reduction: Unlike traditional methods that can slow metabolism or lead to muscle loss, AOD 9604 directly targets fat cells, promoting sustainable weight loss.

• Muscle Sparing: Preserving lean muscle mass is highlighted as a significant advantage, preventing the detrimental effects associated with muscle loss during weight reduction.

• Metabolic Boost: Enhancing the basal metabolic rate (BMR) allows for more efficient energy utilization even at rest, helping individuals break through weight loss plateaus (12:20).

He cautions against relying solely on peptides without maintaining a healthy lifestyle, stressing that AOD 9604 should complement, not replace, proper diet and regular physical activity.

5. Safety Profile and Side Effects

Addressing safety concerns, Dylan underscores that AOD 9604 is well-tolerated with minimal side effects. Unlike HGH, it does not affect IGF-1 levels, alter glucose metabolism, or cause organ overgrowth. Common side effects may include mild injection site reactions like swelling or redness and occasional headaches.

"Dosing for people, I don't want to give a specific dose, I want to be careful with that. But generally Speaking, I see 200 micrograms to 500 micrograms a day" (19:30).

6. AOD 9604 vs. GLP-1s

A significant portion of the episode is dedicated to comparing AOD 9604 with GLP-1 receptor agonists such as semaglutide and tirzepatide:

• GLP-1s Mechanism: These drugs regulate blood sugar levels and appetite, promoting weight loss by reducing hunger and slowing digestion.

• AOD 9604 Mechanism: Focuses on enhancing fat metabolism and sparing muscle without directly impacting blood sugar or insulin resistance.

Dylan discusses the potential of stacking AOD 9604 with GLP-1s to harness the benefits of both, though he notes that AOD 9604 is not FDA approved and must be used off-label. He emphasizes that while GLP-1s may produce rapid weight loss, they might not offer sustainable results and can lead to weight regain once discontinued. In contrast, AOD 9604 provides a more gradual and sustainable approach by targeting fat at the molecular level and preserving muscle mass.

7. Dosage and Administration

AOD 9604 is typically administered via subcutaneous injection once daily, preferably in the morning. Dosage is personalized based on individual weight, metabolic health, and treatment goals. Dylan advises consulting with a healthcare professional to determine the appropriate dosage, generally ranging from 200 to 500 micrograms daily.

8. Future Research and Applications

Dylan highlights ongoing studies exploring AOD 9604's potential in treating various conditions beyond obesity:

• Type 2 Diabetes and Insulin Resistance: Investigating its role in improving insulin sensitivity and stabilizing blood glucose levels.

• Non-Alcoholic Fatty Liver Disease (NAFLD): Considering the high prevalence of NAFLD among individuals with type 2 diabetes, AOD 9604's dual action on fat metabolism and insulin sensitivity positions it as a promising therapeutic option.

He also mentions research into its regenerative properties, particularly in cartilage repair and joint health, suggesting broader applications in musculoskeletal disorders.

9. Conclusion and Final Thoughts

Dylan concludes by reiterating the potential of AOD 9604 as a revolutionary tool in weight management and metabolic health. He emphasizes its comprehensive approach to fat reduction, metabolic enhancement, and joint support, all while maintaining a favorable safety profile.

"I feel AOD and I've seen many people talk about it has the promise of transforming the way we approach weight loss and metabolic health" (28:10).

However, Dylan also cautions listeners about the variability in individual responses and the importance of a holistic approach that includes proper diet, exercise, sleep, and stress management. He stresses that AOD 9604 should be part of a sustainable lifestyle change rather than a standalone solution.

Notable Quotes

• "AOD9604 is actually just a synthetic peptide fragment derived from the C terminal end of human growth hormone." (00:18)

• "It's going to increase your metabolic rate, but the beauty of that is without muscle loss." (00:50)

• "When you're improving joint function and reducing pain, AOD can really help you to increase your physical activity." (13:30)

• "AOD is going to offer a science-backed, targeted approach to fat reduction with added benefits in metabolic health and joint support with a low risk of side effects." (22:45)

• "AOD really is showing a significant advancement in our whole look of weight management and metabolic health." (25:55)

Final Remarks

Dylan Gemelli's in-depth exploration of AOD 9604 in Episode #31 serves as an invaluable resource for individuals seeking advanced and sustainable solutions for weight management and metabolic health. By providing a thorough analysis of its mechanisms, benefits, and safety, Dylan equips listeners with the knowledge needed to make informed decisions about incorporating peptides like AOD 9604 into their health and fitness regimens.

Stay tuned for more insightful discussions on health, fitness, and biohacking with Dylan Gemelli on The Dylan Gemelli Podcast.